Discover ANY AI to make more online for less.

select between over 22,900 AI Tool and 17,900 AI News Posts.

<
New
Agents
Marketing
Video
Image
Music
Coding
Communication
Education
Travel
>

qz
Eli Lilly is buying a biotech startup for nearly $3 billion to expand into autoimmune diseases

The deal adds a pipeline targeting the antibodies behind Graves' disease, thyroid eye disease, food allergy, and other conditions

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine
Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

<p><img width="1536" height="1024" src="https://the-decoder.com/wp-content/uploads/2025/09/medical_ai_illustration-2.png" class="attachment-full size-full w [...]

Match Score: 72.57

An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/c45b4d7b37b7f8cb4e6dd83e52b76b28.jpg"/><p>An Eli Lilly exec said the company†[...]

Match Score: 67.70

Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s
Eli Lilly's online health platform just expanded beyond weight loss to

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e4b70d65bbdfcb4854862d2a597ad777.jpg"/><p>Just about a year after launching a [...]

Match Score: 67.70

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/ff0c1c3c426ad52686faeda3e7ef0e44.jpg"/><p>Eli Lilly’s (<a class="sc- [...]

Match Score: 67.70

qz
UCB is snapping up U.S. autoimmune biotech Candid Therapeutics for $2.2 bil

The Belgian pharma company is paying $2 billion upfront for Candid's pipeline of T-cell engagers targeting autoimmune diseases [...]

Match Score: 61.19

Eli Lilly's first weight-loss pill could expand access to GLP-1s around the globe, executive says
Eli Lilly's first weight-loss pill could expand access to GLP-1s aroun

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/2d2e937f7b7b2059bb3e98c22c58a79d.jpg"/><p>Eli Lilly (<a class="sc-1out [...]

Match Score: 56.56

Eli Lilly CEO David Rick’s’ pay rose to nearly $30 million in 2024
Eli Lilly CEO David Rick’s’ pay rose to nearly $30 million in 2024

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/6478013c8b906ffb19064f747a93b5e2.jpg"/><p>Eli Lilly (<a class="sc-1out [...]

Match Score: 55.72

Eli Lilly promises to make new weight-loss pill in the U.S.
Eli Lilly promises to make new weight-loss pill in the U.S.

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/6f3a3562f2f0c74291f283d1255e2ead.jpg"/><p>Eli Lilly (<a class="sc-1out [...]

Match Score: 54.16

Eli Lilly is coming after makers of copycat versions of Zepbound
Eli Lilly is coming after makers of copycat versions of Zepbound

<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e4b70d65bbdfcb4854862d2a597ad777.jpg"/><p>Eli Lilly (<a class="sc-1out [...]

Match Score: 54.16